Panserin 293S, Serum-free medium for HEK-Cells in suspension culture, w: L-Glutamine
Cell culture medium · RUO (P04-710609)
Panserin 293S is a serum-free medium optimised for suspension HEK293 culture, supporting viral-vector production and recombinant-protein expression. An adherent variant, Panserin 293A, is also available. Adherent variant: Panserin 293A (P04-710608).
One GMP quality. Panserin 293S, Serum-free medium for HEK-Cells in suspension culture, w: L-Glutamine is a catalogue product (P04-710609, GMP on request), manufactured or assured by PAN-Celltech and released against a defined quality-control panel on every lot.
Why
- Suspension HEK293 – for scalable vector / protein production.
- Serum-free – defined, controlled process.
- Adherent option – Panserin 293A for attached culture.
Specification
| Base | Serum-free HEK293 medium |
| Format | Suspension (293S); adherent variant 293A |
| Form | Liquid medium |
| Grade | RUO |
| Storage | 2-8 °C |
Ordering
| Grade | Art. No. | Pack size |
|---|---|---|
| RUO | P04-710609 | 500 ml |
Other pack sizes on request.
In the process – by application (upstream & downstream)
Panserin 293S, Serum-free medium for HEK-Cells in suspension culture, w: L-Glutamine is used at the following process steps across the biologics platforms it supports:
Monoclonal antibodies
- HEK – Serum-free medium for suspension HEK293; DMEM/F12 base; hydrolysates <0.02% w/v; seed 5×10⁶/ml; shaker / spinner / bioreactor.
Cell & gene therapy
- Vector Production / Transfection – Suspension HEK293 vector production.
Vaccines
- Cell expansion – serum-free HEK293 medium for viral vector production.
mRNA
- Cell-based Studies / Transfection (optional) – HEK293 suspension medium for transfection-based mRNA studies.
Frequently asked questions
In which grade is Panserin 293S available?
It is available as a RUO product (P04-710609); a GMP version is available on request.
Which processes is this product used in?
Panserin 293S, Serum-free medium for HEK-Cells in suspension culture, w: L-Glutamine is used across the PAN Monoclonal antibody, Cell & gene therapy and mRNA technology processes. See "In the process – by application (upstream & downstream)" above for the specific steps in each.
One partner across every application. Explore the full catalogue (RUO) or use the Smart Product Search.


